SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-08-005428
Filing Date
2008-08-07
Accepted
2008-08-07 15:40:03
Documents
7
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 IDENIX PHARMACEUTICALS, INC. b71175ipe10vq.htm 10-Q 483759
2 EX-10.1 MASTER SERVICES AGREEMENT WITH PAREXEL INTERNATIONAL LLC b71175ipexv10w1.htm EX-10.1 67499
3 EX-31.1 SECTION 302 CERTIFICATION OF CEO b71175ipexv31w1.htm EX-31.1 5791
4 EX-31.2 SECTION 302 CERTIFICATION OF CFO b71175ipexv31w2.htm EX-31.2 6057
5 EX-32.1 SECTION 906 CERTIFICATION OF CEO b71175ipexv32w1.htm EX-32.1 3741
6 EX-32.2 SECTION 906 CERTIFICATION OF CFO b71175ipexv32w2.htm EX-32.2 3472
7 GRAPHIC b71175ipb7117501.gif GRAPHIC 1690
  Complete submission text file 0000950135-08-005428.txt   574257
Mailing Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 60 HAMPSHIRE STREET . CAMBRIDGE MA 02139 (617) 250-3100
IDENIX PHARMACEUTICALS INC (Filer) CIK: 0001093649 (see all company filings)

IRS No.: 450478605
Type: 10-Q | Act: 34 | File No.: 000-49839 | Film No.: 08998371
SIC: 2834 Pharmaceutical Preparations